Beijing Tong Ren Tang Chinese Medicine Company Limited

Informe Stock SEHK:3613

Capitalización de mercado: HK$7.7b

Dividendos de Beijing Tong Ren Tang Chinese Medicine

Dividendo controles de criterios 3/6

Beijing Tong Ren Tang Chinese Medicine es una empresa que paga dividendos con una rentabilidad actual de 3.51% que está bien cubierta por los beneficios. La próxima fecha de pago es en 17th June, 2024 con una fecha ex-dividendo de 4th June, 2024.

Información clave

3.6%

Rentabilidad por dividendo

51%

Ratio de pago

Rentabilidad media de la industria3.6%
Próxima fecha de pago de dividendos17 Jun 24
Fecha ex dividendo04 Jun 24
Dividendo por acciónn/a
Beneficios por acciónHK$0.65
Rentabilidad por dividendo prevista a 3 años5.7%

Últimas actualizaciones de dividendos

Beijing Tong Ren Tang Chinese Medicine (HKG:3613) Has Announced That It Will Be Increasing Its Dividend To HK$0.28

Apr 28
Beijing Tong Ren Tang Chinese Medicine (HKG:3613) Has Announced That It Will Be Increasing Its Dividend To HK$0.28

Recent updates

Beijing Tong Ren Tang Chinese Medicine Company Limited's (HKG:3613) 28% Share Price Plunge Could Signal Some Risk

Feb 05
Beijing Tong Ren Tang Chinese Medicine Company Limited's (HKG:3613) 28% Share Price Plunge Could Signal Some Risk

Calculating The Intrinsic Value Of Beijing Tong Ren Tang Chinese Medicine Company Limited (HKG:3613)

Jan 03
Calculating The Intrinsic Value Of Beijing Tong Ren Tang Chinese Medicine Company Limited (HKG:3613)

A Look At The Intrinsic Value Of Beijing Tong Ren Tang Chinese Medicine Company Limited (HKG:3613)

Sep 28
A Look At The Intrinsic Value Of Beijing Tong Ren Tang Chinese Medicine Company Limited (HKG:3613)

Here's Why We Think Beijing Tong Ren Tang Chinese Medicine (HKG:3613) Might Deserve Your Attention Today

Jul 12
Here's Why We Think Beijing Tong Ren Tang Chinese Medicine (HKG:3613) Might Deserve Your Attention Today

Is Now The Time To Put Beijing Tong Ren Tang Chinese Medicine (HKG:3613) On Your Watchlist?

Mar 29
Is Now The Time To Put Beijing Tong Ren Tang Chinese Medicine (HKG:3613) On Your Watchlist?

Beijing Tong Ren Tang Chinese Medicine (HKG:3613) Has Announced That It Will Be Increasing Its Dividend To HK$0.28

Apr 28
Beijing Tong Ren Tang Chinese Medicine (HKG:3613) Has Announced That It Will Be Increasing Its Dividend To HK$0.28

Beijing Tong Ren Tang Chinese Medicine (HKG:3613) Will Pay A Larger Dividend Than Last Year At HK$0.28

Mar 25
Beijing Tong Ren Tang Chinese Medicine (HKG:3613) Will Pay A Larger Dividend Than Last Year At HK$0.28

Are Beijing Tong Ren Tang Chinese Medicine Company Limited (HKG:3613) Investors Paying Above The Intrinsic Value?

Oct 27
Are Beijing Tong Ren Tang Chinese Medicine Company Limited (HKG:3613) Investors Paying Above The Intrinsic Value?

Beijing Tong Ren Tang Chinese Medicine's (HKG:3613) Sluggish Earnings Might Be Just The Beginning Of Its Problems

Apr 28
Beijing Tong Ren Tang Chinese Medicine's (HKG:3613) Sluggish Earnings Might Be Just The Beginning Of Its Problems

Read This Before Selling Beijing Tong Ren Tang Chinese Medicine Company Limited (HKG:3613) Shares

Mar 11
Read This Before Selling Beijing Tong Ren Tang Chinese Medicine Company Limited (HKG:3613) Shares

What Type Of Returns Would Beijing Tong Ren Tang Chinese Medicine's(HKG:3613) Shareholders Have Earned If They Purchased Their SharesYear Ago?

Feb 04
What Type Of Returns Would Beijing Tong Ren Tang Chinese Medicine's(HKG:3613) Shareholders Have Earned If They Purchased Their SharesYear Ago?

Should Beijing Tong Ren Tang Chinese Medicine Company Limited (HKG:3613) Be Part Of Your Dividend Portfolio?

Jan 18
Should Beijing Tong Ren Tang Chinese Medicine Company Limited (HKG:3613) Be Part Of Your Dividend Portfolio?

Could The Beijing Tong Ren Tang Chinese Medicine Company Limited (HKG:3613) Ownership Structure Tell Us Something Useful?

Dec 29
Could The Beijing Tong Ren Tang Chinese Medicine Company Limited (HKG:3613) Ownership Structure Tell Us Something Useful?

Read This Before Selling Beijing Tong Ren Tang Chinese Medicine Company Limited (HKG:3613) Shares

Dec 11
Read This Before Selling Beijing Tong Ren Tang Chinese Medicine Company Limited (HKG:3613) Shares

Beijing Tong Ren Tang Chinese Medicine Company Limited's (HKG:3613) Stock's On An Uptrend: Are Strong Financials Guiding The Market?

Nov 23
Beijing Tong Ren Tang Chinese Medicine Company Limited's (HKG:3613) Stock's On An Uptrend: Are Strong Financials Guiding The Market?

Próximo pago de dividendos

HoyApr 12 2024Fecha ex dividendoJun 04 2024Fecha de pago de dividendosJun 17 202413 days desde ex dividendoCompra en los próximos 53 days para recibir el próximo dividendo

Estabilidad y crecimiento de los pagos

Obteniendo datos sobre dividendos

Dividendo estable: El pago de dividendos de 3613 ha sido volátil en los últimos 10 años.

Dividendo creciente: 3613 El pago de dividendos ha aumentado en los últimos 10 años.


Rentabilidad por dividendo vs. Mercado

Rentabilidad por dividendo de Beijing Tong Ren Tang Chinese Medicine vs. Mercado
¿Cómo se compara la rentabilidad por dividendo de 3613 con la del mercado?
SegmentoRentabilidad por dividendo
Empresa (3613)3.6%
Suelo de mercado 25% (HK)3.3%
Techo de mercado 25% (HK)8.1%
Media de la industria (Pharmaceuticals)3.6%
Previsión de analistas en 3 años (3613)5.7%

Dividendo destacado: 3613(3.47%) es superior al 25% inferior de los pagadores de dividendos del mercado Hong Kong (3.32%).

Alto dividendo: 3613(3.47%) es bajo en comparación con el 25% de los principales pagadores de dividendos del mercado Hong Kong (8.51%).


Pago de beneficios a los accionistas

Cobertura de los beneficios: Con su razonable ratio de reparto (51.1%), los pagos de dividendos de 3613 están cubiertos por los beneficios.


Pago en efectivo a los accionistas

Cobertura de flujo de caja: Datos insuficientes para calcular el ratio de reparto de efectivo de 3613 para determinar si sus pagos de dividendos están cubiertos por los flujos de caja.


Discover strong dividend paying companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target